Overview

Study to Investigate the Effect of Heart Rate Reduction With Ivabradine on Vascular Elastic Properties and Endothelial Function in Patients With Stable Coronary Heart Disease

Status:
Unknown status

Trial end date:
2014-12-01

Target enrollment:

Participant gender:

Summary

This study investigates whether chronic heart rate reduction with ivabradine (Procoralan®, Servier, France) affects aortic compliance and endothelial function in patients with chronic stable coronary artery disease.

Phase:

Phase 4

Details

Lead Sponsor:

University Hospital, Saarland

Collaborators:

Saarland University
Universität des Saarlandes